Pacira BioSciences (PCRX) News Today $26.67 -0.18 (-0.67%) Closing price 04:00 PM EasternExtended Trading$26.67 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PCRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Pacira BioSciences, Inc. $PCRX Shares Bought by Wellington Management Group LLPAugust 29 at 3:57 AM | marketbeat.comQuantbot Technologies LP Purchases 24,102 Shares of Pacira BioSciences, Inc. $PCRXAugust 28 at 4:41 AM | marketbeat.comMartingale Asset Management L P Takes Position in Pacira BioSciences, Inc. $PCRXAugust 27 at 5:03 AM | marketbeat.comAmerican Century Companies Inc. Increases Holdings in Pacira BioSciences, Inc. $PCRXAugust 27 at 3:47 AM | marketbeat.comCharles Schwab Investment Management Inc. Grows Stock Holdings in Pacira BioSciences, Inc. $PCRXAugust 26 at 3:19 AM | marketbeat.comPacira BioSciences, Inc. $PCRX Shares Bought by Invesco Ltd.August 25, 2025 | marketbeat.comNuveen LLC Makes New Investment in Pacira BioSciences, Inc. $PCRXAugust 24, 2025 | marketbeat.comPacira BioSciences, Inc. $PCRX Shares Sold by Vanguard Group Inc.August 24, 2025 | marketbeat.comPacira BioSciences, Inc. $PCRX Shares Bought by Public Sector Pension Investment BoardAugust 19, 2025 | marketbeat.comDeutsche Bank AG Trims Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)August 17, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.August 15, 2025 | marketbeat.comNatixis Advisors LLC Invests $327,000 in Pacira BioSciences, Inc. (NASDAQ:PCRX)August 14, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Director Marcelo Bigal Sells 4,912 SharesAugust 12, 2025 | marketbeat.comMarcelo Bigal Sells 4,912 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) StockAugust 12, 2025 | insidertrades.comPacira BioSciences, Inc. (NASDAQ:PCRX) Stock Position Lifted by Global Alpha Capital Management Ltd.August 11, 2025 | marketbeat.comGagnon Securities LLC Has $7.66 Million Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)August 8, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comPacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Recommendation of "Hold" from AnalystsAugust 7, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Releases Earnings Results, Misses Expectations By $0.26 EPSAugust 6, 2025 | marketbeat.comPacira outlines narrowed $730M–$750M revenue guidance and increased margin targets as J&J ZILRETTA partnership takes shapeAugust 6, 2025 | msn.comPacira BioSciences, Inc. (PCRX) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comPacira BioSciences, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 6, 2025 | seekingalpha.comPacira reports Q2 EPS 74c, consensus 71cAugust 6, 2025 | msn.comPacira (PCRX) Tops Q2 Earnings EstimatesAugust 6, 2025 | msn.comInsights Ahead: Pacira BioSciences's Quarterly EarningsAugust 6, 2025 | benzinga.comPacira BioSciences Reports Second Quarter 2025 Financial ResultsAugust 5, 2025 | globenewswire.comWhat To Expect From Pacira BioSciences Inc (PCRX) Q2 2025 EarningsAugust 4, 2025 | finance.yahoo.comPhocas Financial Corp. Acquires Shares of 142,443 Pacira BioSciences, Inc. (NASDAQ:PCRX)August 4, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Banco Santander S.A.August 4, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Takes Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)August 4, 2025 | marketbeat.comJefferies Financial Group Inc. Decreases Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)August 3, 2025 | marketbeat.comPacira BioSciences: Worth Pondering, Strong Balance SheetJuly 29, 2025 | seekingalpha.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Pacer Advisors Inc.July 27, 2025 | marketbeat.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Acquired by Victory Capital Management Inc.July 27, 2025 | marketbeat.comPacira BioSciences (NASDAQ:PCRX) Stock Rating Upgraded by Truist FinancialJuly 26, 2025 | marketbeat.comPacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025July 24, 2025 | globenewswire.comLegato Capital Management LLC Sells 14,040 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)July 24, 2025 | marketbeat.comPacira collabs with J&J’s MedTech to expand market reach of ZILRETTAJuly 23, 2025 | msn.comPacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional EffortsJuly 23, 2025 | finance.yahoo.comPacira BioSciences (PCRX) to Release Earnings on TuesdayJuly 22, 2025 | marketbeat.comZacks Research Has Negative Estimate for PCRX Q4 EarningsJuly 21, 2025 | marketbeat.comInvestors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with LawsuitJuly 16, 2025 | prnewswire.comAllspring Global Investments Holdings LLC Makes New $277,000 Investment in Pacira BioSciences, Inc. (NASDAQ:PCRX)July 12, 2025 | marketbeat.comPacira BioSciences to Close Manufacturing Suite, Lay Off 71 EmployeesJuly 10, 2025 | marketwatch.comPacira announces layoffs due to efficiencies in Exparel productionJuly 10, 2025 | msn.comPacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 3, 2025 | globenewswire.comRobeco Institutional Asset Management B.V. Purchases 12,750 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)July 2, 2025 | marketbeat.comPacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025June 18, 2025 | finance.yahoo.comPACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJune 17, 2025 | globenewswire.comPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Assenagon Asset Management S.A.June 14, 2025 | marketbeat.com Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PCRX Media Mentions By Week PCRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCRX News Sentiment▼1.771.04▲Average Medical News Sentiment PCRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCRX Articles This Week▼99▲PCRX Articles Average Week Get the Latest News and Ratings for PCRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Perrigo News Today Supernus Pharmaceuticals News Today Nektar Therapeutics News Today Omeros News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Eli Lilly and Company News Today Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCRX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access